Next Article in Journal
Synergistic Anti-Tumor Effect of Palmitoylcarnitine and Dasatinib in Liver Cancer
Previous Article in Journal
Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?
 
 
Due to scheduled maintenance work on our servers, there may be short service disruptions on this website between 11:00 and 12:00 CEST on March 28th.
Article

Article Versions Notes

Livers 2022, 2(4), 336-343; https://doi.org/10.3390/livers2040025
Action Date Notes Link
article html file updated 3 September 2025 01:42 CEST Update https://www.mdpi.com/2673-4389/2/4/25/html
article html file updated 1 March 2023 23:28 CET Update -
article html file updated 21 October 2022 11:21 CEST Update -
article xml uploaded. 21 October 2022 11:20 CEST Update https://www.mdpi.com/2673-4389/2/4/25/xml
article xml file uploaded 21 October 2022 11:20 CEST Update -
article html file updated 21 October 2022 11:04 CEST Original file -
article pdf uploaded. 21 October 2022 11:02 CEST Version of Record https://www.mdpi.com/2673-4389/2/4/25/pdf
article xml uploaded. 21 October 2022 11:02 CEST Update -
article xml file uploaded 21 October 2022 11:02 CEST Original file -
Back to TopTop